Oracle's Dual-Pronged Strategy Aims to Justify a Massive Investment Bet

Oracle's revenue surges 22% with cloud up 84%, but heavy AI and cloud investments push free cash flow negative and debt over $124B, pressuring the stock.

Oracle shares have been on a rollercoaster, but the company is making moves to prove its strategy is sound. In a single day this April, the tech giant announced two major strategic developments, one in healthcare data and another in cloud infrastructure, showcasing the breadth of its growth initiatives.

The company's financials present a picture of robust operational growth shadowed by significant spending. For its third fiscal quarter of 2026, total revenue surged 22% to $17.2 billion. The cloud infrastructure segment, its fastest-growing unit, skyrocketed 84% to $4.9 billion. Cloud revenue now constitutes 52% of Oracle's total business. Bolstered by long-term AI infrastructure deals, the company's backlog of unfulfilled orders climbed to $553 billion. For fiscal 2027, Oracle has raised its revenue outlook to $90 billion, exceeding prior analyst expectations.

However, the stock's performance tells a different story. Despite a recent weekly gain of nearly 14%, including a 3.55% rise on April 16 while the broader software sector fell 2.21%, the shares remain under pressure. Trading around €149, the stock sits nearly 19% below its 200-day moving average and almost 47% off its 52-week high. A Relative Strength Index (RSI) reading of 19 indicates deeply oversold conditions. The market capitalization currently stands at approximately $497 billion.

The pressure stems from Oracle's aggressive investment pace. Capital expenditures of roughly $50 billion in the current fiscal year are pushing free cash flow into negative territory and driving total debt above $100 billion. Long-term debt now exceeds $124 billion. Concurrently, the company is cutting between 20,000 and 30,000 positions to reallocate resources toward artificial intelligence.

The twin announcements are central to Oracle's attempt to validate this spending. In healthcare, Oracle Health has been designated a CMS Aligned Network by the U.S. Centers for Medicare & Medicaid Services. This allows patients to check in digitally via QR code, share their health data, and have it flow directly into their electronic health records, eliminating redundant paperwork. The technical integration uses CLEAR1, certified to the NIST IAL2/AAL2 standard, with initial pilot tests underway at U.S. healthcare provider AtlantiCare. This status complements Oracle's existing role as a Qualified Health Information Network under the federal TEFCA framework.

On the infrastructure front, Oracle is finally plugging the last major gap in its multicloud network. The company announced a high-speed private connection between Oracle Cloud Infrastructure (OCI) and Amazon Web Services (AWS), with launch planned for later this year in the AWS US East (N. Virginia) region. This follows existing interconnects with Google Cloud and Microsoft Azure. The direct link, offering up to 100 Gbps bandwidth, allows enterprises to run applications like an Oracle database on OCI combined with AWS SageMaker for model training without the latency of the public internet.

Analysts view Oracle as the second-largest cloud provider by order backlog, just behind Microsoft Azure with over $600 billion and ahead of AWS with around $350 billion. A potential risk buffer is OpenAI's recent $122 billion funding round, which secures compute capacity at Oracle, Microsoft, and Amazon for the next two to three years, though projects like the Stargate data center in Texas have seen OpenAI shift expansion plans due to demand for newer Nvidia GPUs.

The 33 analysts currently rating Oracle a "Buy" have price targets ranging from $160 to $400, reflecting deep divisions over the sustainability of the AI infrastructure boom. Whether customer demand across healthcare and enterprise cloud can justify Oracle's breakneck investment tempo will become clearer when the company reports its next quarterly results in June.